A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies.
about
Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesManagement of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future PerspectivesNeuropsychiatric lupus: a mosaic of clinical presentationsManagement of the antiphospholipid syndromeCurrent treatment of antiphospholipid syndrome: lights and shadows.Therapeutic challenges after successful thrombectomy in a patient with an antiphospholipid syndrome associated M1-occlusion: A case report.Diagnosis of antiphospholipid syndrome in routine clinical practiceGuidelines for the treatment of antiphospholipid syndrome.Cerebral embolism from Libman-Sacks endocarditis.Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future Approaches.Prevalence of the antiphospholipid syndrome and its effect on survival in 679 Chinese patients with systemic lupus erythematosus: a cohort study.Identification of a Monoclonal Antibody That Attenuates Antiphospholipid Syndrome-Related Pregnancy Complications and Thrombosis.Thrombosis in systemic lupus erythematosus: a review articleLatest advances in connective tissue disorders.Thrombin generation as marker to estimate thrombosis risk in patients with abnormal test results in lupus anticoagulant routine diagnostics.Successful Anticoagulation Therapy for Antiphospholipid Syndrome with Mobile Aortic Thrombi.Neuropsychiatric Systemic Lupus Erythematosus Involvement: Towards a Tailored Approach to Our Patients?Domain I of beta2-glycoprotein I: its role as an epitope and the potential to be developed as a specific target for the treatment of the antiphospholipid syndrome.Towards evidence-based treatment of thrombotic antiphospholipid syndrome.Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment.Cutting-edge issues in coronary disease and the primary antiphospholipid syndrome.Neuropsychiatric manifestations in systemic lupus erythematosus: epidemiology, pathophysiology and management.Management of obstetric antiphospholipid syndrome.Guidelines on the investigation and management of antiphospholipid syndrome.Secondary prevention in thrombotic antiphospholipid syndrome.Duration of anticoagulation treatment for thrombosis in APS: is it ever safe to stop?Catastrophic wounds.Management of recurrent thrombosis in antiphospholipid syndrome.Diagnosis and management of neuropsychiatric SLE.Intensity of anticoagulation in the treatment of thrombosis in the antiphospholipid syndrome: a meta-analysis.Reviewing the recommendations for lupus in children.Antiphospholipid syndrome: an update.Antiphospholipid syndrome presenting as cerebral venous sinus thrombosis: a case series and a review.Pharmacologic management of neuropsychiatric lupus.Prevention of Recurrent Thrombosis in Antiphospholipid Syndrome: Different from the General Population?Current status and future prospects for the treatment of antiphospholipid syndrome.Immunotherapeutic strategies in antiphospholipid syndrome.Stroke in systemic lupus erythematosus and antiphospholipid syndrome: risk factors, clinical manifestations, neuroimaging, and treatment.The antiphospholipid syndrome: from pathophysiology to treatment.Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
P2860
Q24632951-5FC172CC-9DB8-4D03-85E2-A5CEDA8E5F5BQ26774815-4ED800E4-B372-4F07-A30E-EE01C650312FQ27027588-8BC9D787-9F85-42BF-8C7F-3EC1F314885DQ33423034-FCE74F4B-DA15-4329-93E0-391BC97EAB1EQ33423959-12E3AF30-7D7A-46B1-A2F8-866CDE707B5AQ33424085-C87B9FFF-17C0-4044-B801-ADA1092C07E4Q33939826-EEA3F1F5-F29D-46B5-BC25-2D9436C84A9FQ34821893-72A60BB2-64E7-4186-80A5-D40F9F7DC71DQ35094631-C755EBF9-EB67-477C-8CA6-3EB67F13FDA1Q35621012-A093CD0A-6E3D-40DE-B071-8669616D941DQ36008969-CAEDA5A1-27E9-40B4-ACEB-2C09724CBE39Q36087118-295FFB69-6900-4DAD-9F63-A580445F1C34Q36147794-50D1B7EE-3283-4A01-9C86-908DC9C616E4Q37058776-BD806915-4487-456D-992C-0C3612486301Q37347979-3B7F86D0-94AD-41FB-B8E6-F6E4193CB5B3Q37543887-FB25809F-8339-4C1C-A0BB-351C3329492CQ37632131-3C1BAAA5-EF21-4A44-ABC7-C7A232952EFBQ37721607-99E475D8-BE57-41E1-9485-98D388E76455Q37721614-8F5AB31A-8F2B-4F6F-A8DD-6F20D6D84E9DQ37842673-97DCE772-1EE0-467C-A0F0-5088A3DD0D2CQ37853050-18433D44-162D-481E-BCAB-795F99B4E41DQ37922765-F9A3174D-436A-471F-AA13-FC67C6749D94Q37959314-2839F0E8-E0EE-4F4A-B173-D7834D7797D2Q37982121-89BCD5D2-AEEF-4670-883D-7D2838A0F90EQ38013589-8BBF5F7C-2634-4A43-8316-1777090D12E4Q38089684-CDD41C73-7CBD-4046-8835-39B2E6290EA8Q38154328-E1FE832C-27FE-434D-B098-B7CD4587AB62Q38180647-01AA5B1A-0997-4182-8085-BADCC3FD4AE2Q38186995-A94ABEF1-9F69-4644-B357-2B8DACC31820Q38273875-EFE6D33E-2D9F-4505-9B92-4A7A6731CEEFQ38374309-A4461CA1-3E32-4A3B-B01E-1F8452F28C81Q38410376-17EA399D-A6AB-4F1A-ADD4-1B4C0B37FFAFQ38596401-800C491F-9F8F-4572-B9B1-50491ABBA96BQ38630775-B672B39F-9396-405E-997D-1B96B3BABA5FQ38794847-3106E3F9-F817-4DB9-BF18-8921F332CBCBQ38818425-502B50CC-264B-4846-AD46-A540DA286DF1Q38826804-0CF3406E-ED8F-4C83-AE39-E17CA7D16B82Q38844621-47A3E735-24AD-4334-AD06-D03FF64B7C83Q38873953-4E2F1E6B-3737-407F-8B54-C1794099C3ECQ39138695-A88A7361-59F3-4B07-ACF8-4D8B4FBEFE5A
P2860
A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A systematic review of seconda ...... h antiphospholipid antibodies.
@en
A systematic review of seconda ...... h antiphospholipid antibodies.
@nl
type
label
A systematic review of seconda ...... h antiphospholipid antibodies.
@en
A systematic review of seconda ...... h antiphospholipid antibodies.
@nl
prefLabel
A systematic review of seconda ...... h antiphospholipid antibodies.
@en
A systematic review of seconda ...... h antiphospholipid antibodies.
@nl
P356
P1476
A systematic review of seconda ...... h antiphospholipid antibodies.
@en
P2093
Beverley J Hunt
P304
P356
10.1002/ART.23109
P577
2007-12-01T00:00:00Z